Clinical Trials Logo

Filter by:
NCT ID: NCT00832728 Withdrawn - Clinical trials for Fulminant Hepatic Failure

Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)

ELAD
Start date: March 2009
Phase: Phase 2
Study type: Interventional

This is a multicenter, open-label, randomized, concurrent control study of subjects with FHF. Subjects meeting the eligibility requirements of the study will be randomly assigned in a 2:1 ratio to receive either standard medical therapy for FHF plus the ELAD® system, or standard medical therapy alone, with the latter defined as conventional therapy for FHF determined to be clinically appropriate by the treating physician.

NCT ID: NCT00832364 Withdrawn - Plaque Psoriasis Clinical Trials

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

Start date: October 2009
Phase: Phase 4
Study type: Interventional

The purpose of the study is to assess the safety and efficacy of an injectable biologic and U0279 as combination therapy compared to that of an injectable biologic alone for severe plaque-type psoriasis.

NCT ID: NCT00832065 Withdrawn - Sleep Apnea Clinical Trials

Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome

Start date: January 2009
Phase: N/A
Study type: Observational

Obstructive Sleep Apnea Syndrome (OSAS)is a common disease and is suspected to be associated with sexual dysfunction. Our purpose is to sudy the effect of CPAP (Continuous Positive Airway Pressure) treatment on patients' sexual dysfunction by measuring testosterone levels before and after CPAP treatments.

NCT ID: NCT00830479 Withdrawn - Clinical trials for Vesicoureteral Reflux

Study of Endoscopic Versus Open Surgery for Urinary Reflux

STRETCH
Start date: January 2009
Phase: N/A
Study type: Interventional

This study seeks to compare outcomes after anti-reflux surgery (ARS) for correction of low-grade vesicoureteral reflux (VUR). It is a randomized controlled open-label trial of conventional open anti-reflux technique versus endoscopic anti-reflux technique with injection of dextranomer/hyaluronic acid copolymer (Deflux). Primary endpoint will be resolution of VUR at initial cystogram after ARS. Secondary outcomes will include incidence of postoperative UTI, resolution of VUR at 1-year cystogram after ARS, surgical complications, and quality of life measures after ARS.

NCT ID: NCT00829608 Withdrawn - Clinical trials for Recurrent Respiratory Papillomatosis

Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis

Start date: January 2009
Phase: Phase 0
Study type: Interventional

The purpose of this study is to determine if administration of the HPV quadrivalent vaccine in patients diagnosed with RRP has a therapeutic effect on their clinical course. More specifically, does administration of the vaccine decrease the size and number of papillomas, severity of disease (i.e. hoarseness, inspiratory vs. biphasic stridor, airway obstruction) using the LCAS and time interval between required surgical debulking will be analyzed.

NCT ID: NCT00829062 Withdrawn - Type 1 Diabetes Clinical Trials

Expanding Coverage of Continuous Subcutaneous Insulin Infusion in Pediatric Patients With Diabetes

Start date: January 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to present evidence based literature and clinical data to the medical directors at Missouri Medicaid to help modify the existing policy regarding insulin pump therapy in pediatric patients with diabetes.

NCT ID: NCT00827645 Withdrawn - Incontinence Clinical Trials

Uterine Artery Embolization and Pelvic Floor Symptoms

Start date: January 1, 2009
Phase:
Study type: Observational

The objective of this study is to determine whether women who are already receiving treatment for their fibroids (ie. UAE) demonstrate improvement in urinary symptoms and sexual dysfunction as well.

NCT ID: NCT00827281 Withdrawn - Smokers Clinical Trials

D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)

Start date: August 2008
Phase: Phase 2
Study type: Interventional

This study examines whether isolated doses of D-cycloserine enhance the efficacy of CBT for smoking cessation.

NCT ID: NCT00827151 Withdrawn - Bone Loss Clinical Trials

Bone Mass Accrual in Adolescent Athletes

838
Start date: December 2008
Phase: Phase 3
Study type: Interventional

The adolescent and young adult years are a critical window in time for bone mineral accrual. More than 90% of peak bone mass is achieved by 18 years, and data indicate that insults sustained during adolescence and young adulthood may result in permanent deficits in bone accrual. Adult athletes with amenorrhea (AA) have low bone mineral density (BMD) secondary to hypogonadism, associated with increased fracture risk and associated co-morbidities. We will examine whether estrogen replacement will increase BMD and improve measures of bone microarchitecture in adolescents and young women with AA, thus optimizing peak bone mass.

NCT ID: NCT00826839 Withdrawn - Infertility Clinical Trials

Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients

OMLET
Start date: January 2009
Phase: Phase 4
Study type: Interventional

Hundreds of thousands of couples in the United States experience infertility each year. When initial measures do not help, some couples require a process called ovarian stimulation and in vitro fertilization (IVF). Usually, a woman produces at most one egg each month. Ovarian stimulation helps these women make more than one egg per month. However, this involves taking hormones that stimulate the ovary to produce many eggs at one time. The stimulatory hormones injected with a small needle. The eggs are removed from the ovary through a surgical procedure and then placed in a dish for fertilization by sperm to form embryos. The embryos are grown in the laboratory then replaced into the woman's uterus 3-5 days later. The stimulation of the ovaries is important. Some patients undergo ovarian stimulation for IVF but do not respond to the treatment. This is a very difficult situation because even though several ovarian stimulation protocols have been used for poor responder patients, it is not clear which protocol works best. In fact, two of the most commonly used protocols have not been directly compared. This study will randomize (like flipping a coin) couples with a history of low response who are going to start IVF treatment into two groups. In one group the female partner will use a protocol called "E2 patch/antagonist". These women will use an estrogen patch and injected antagonist for several days before starting injectable fertility medications. The other group will use a protocol called "OCP/microdose". This group of women will use oral contraceptive pills (OCPs) and small doses of lupron along with the other injectable fertility medications. We will then follow their progress to see how many eggs they produce and how many women get pregnant.